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1107-139 Metabolic Syndrome Is Highly Prevalent in Patients 
With Coronary Artery Disease 
Prakash C. Deedwania, Nini C. Thomas, Kern Brar, VA Central California Health Care 
System, Fresno. CA, UCSF School of Medicine, San Francisco, CA 
Backqround: Recent Adult Treatment Panel III (ATP Ill) guidelines have emphasized the 
sigmficance of metabolic syndrome (MS) as an important risk factor for coronary artery 
disease (CAD). However, the prevalence of MS in CAD patients is not known. Accord- 
ingly, we evaluated the prevalence of MS among patients with established diagnosis of 
CAD at our Medical Center. 
Method: A random group of 668 patients with established diagnosis of CAD was selected 
from computer records of VACCHCS. Fresno. Patients’ age, HR, BP, height, weight, 
body mass index, FBS. and total, LDL and HDL cholesterols were recorded. History of 
treatment for diabetes. hypertension, or dyskpidemia was also recorded. Diagnosis of 
MS was based on ATP Ill guidelines. Statistical analyses were done using the Chi- 
Square test for categorical variables and the t-test. for continuous vanables. 
Results: The study population consisted of 668 men with CAD (mean age 69 yrs). Of 
these, 570 were found to have MS, giving a prevalence of 75% (Cl 72%-78%, p value < 
,001). Of the MS patients, 77% and 87% were found to have dyslipidemia and hyperten- 
sion, respectively (p value < .OOOl for both). The table below shows the mean values of 
Important variables in patients with (+) and without (-) MS 
Conclusion: These data suggest that MS is highly prevalent among patients with CAD. 
Future prospective studies should evaluate the risk of CAD in patients with MS. 
Variable Metabolic Syndrome + Metabolic Syndrome - P-value 
Age (years) 69 71 0.014 
Pulse (bpm) 69 70 0.307 
Systolic (mm Hg) 141 130 0.015 
Diastolic (mm Hg) 72 69 0.004 
BMI (kg/n?) 31 26 0.0001 
T. Cholesterol (mg/dl) 179 174 0.198 
LDL (mg/dl) 99 106 0.07 
HDL (mg/dl) 43 46 0.158 
FBS (mgdl) 133 103 o.oooi 
1107-140 The Impact of Moderate Elevations of Blood Pressure 
and Low-Density Lipoprotein Chlosterol on Coronary 
Heart Disease Risk 
Peter W. Wilson. Ralph B. D’Agostino, Sr.. Lisa Sullwan, Daniel Levy. Boston University, 
Boston, MA, National Heart, Lung, and Blood Institute, Framingham, MA 
The effects of moderately elevated lipid levels and blood pressure on coronary heart dis- 
ease (CHD) nsk were examined in Framingham Heart Study participants 30-74 years of 
age at baseline. Risk factors assessed included systolic blood pressure (SBP). LDL cho- 
lesterol (LDL-C), age, sex. diabetes status, and history of cigarette smoking. SEP cate- 
gories (<140, 140.159,>160 mm Hg) and LDL-C levels (<loo, 100-129, 130.159, ,160 
mg/dl) were key components in the analyses. Men and women contributed 3952 and 
4489 person-exams of experience respectively and were followed 12 years for the onset 
of new CHD (angina pectoris. myocardial infarction or coronary death). Analyses used 
age-adjusted Cox models and persons with highly elevated SEIP, highly elevated LDL-C, 
or moderate elevations of both factors experienced greater CHD risk in comparisons with 
a referent group that had SBP ~140 mm Hga LDL-C < 100 mgidl (see table, where * 
denotes P<O.Ol vs referent after age adjustment). Furthermore, moderately elevated 
LDL-C and SBP frequently coexist and the CHD risk related to this combination did not 
differ from that for the highly elevated LDL-C or highly elevated SBP groups. These 
results emphasize the need for awareness, diagnosis and treatment of persons with 
moderately increased blood pressure and lipld levels. 
Group 
BP, LDL-C and CHD R,sk 
Group Criteria Frequency IOyrCHD 
(umts mm Hg and mg/dl) Men I risk 
Women Men i 
Women 
Referent 
Mod Elev SBP and 
LDL-C 
Highly Elev LDL-C 
Highly Elev SBP 
SBP cl40 and LDL-C cl00 11 %ll7% 5%/0.7% 
SBP (140-259) and LDL-C (100. lis/d 8% 17%./l 2%’ 
159) 
LDL-C>tGO 25%l25% 19%‘/12%’ 
SBP 1160 7%/7% 24%*/l 4/%’ 
1107-141 Decreased Activities of Paraoxonase and High-Density- 
Lipoprotein Associated Platelet Activating Factor 
Acetylhydrolase in Hemodialysis Patients 
Bo Zhanq, Satoshi Eta, Ping Fan, Eiso Shimoji. Keijiro Saku. Fukuoka University, 
Fukuoka, Japan 
Background: HDL IS antlatherogenlc partly because of its antloxidatlve and antm-flamma- 
tory properties, in which paraoxonase (Pant), which protects LDL from oxidation, and 
HDL-associated PAF acetylhydrolase (PAF-AH), which degrades PAF and orldizes 
phosphatidylcholine, play an important role. Since patients with chronic renal failure have 
an increased cardiovascular risk and reduced HDL-C levels, we examined whether 
patients on hemodlalysis (HD) have altered activities of Ponl and HDL-associated PAF- 
AH (HDL-PAF-AH). 
Methods: Eighty-seven male non-diabetic HD patients and 73 normal male subjects were 
measured with regard to serum lipids, lipoproteins, Ponl activity with paraoxon as sub- 
strate, and plasma PAF-AH activity and HDL-PAF-AH activity with a specific substrate 
(Azwell Inc.). 
Results: Ponl and HDL-PAF-AH were correlated with HDL-C levels (r=0.30 and 0.38. 
p<O.Ol) in all of the subjects. HD patients had lower (~~0.05) levels of TC, TG, HDL-C, 
and plasma PAF-AH (391 * 155 vs. 453 r 145 /U/L) than controls. Activities of Ponl (770 
* 242 vs. 1014 f 379 IV/L) and HDL-PAF-AH (75 f 26 vs. 117 * 36 IU/L) were also lower 
(~~0.05) in HD patients than in controls. Similar results were obtained after adjusting for 
HDL-C (Rgure) by a General Linear Model, suggestmg that Ponl and HDL-PAF-AH 
were associated with chronic renal failure independent of serum HDL-C levels. 
Conclusion: The reduced Ponl and HDL-associated PAF-AH may contribute to cardio- 
vascular risk independent of HDL-C levels in HD patients. 
1107-142 Comparative Value of Carotid Ultrasound, High 
Sensitivity C-Reactive Protein, and Low-Oensitv 
Lipoprotein Particle Size in Predicting Coronar; Artery 
Disease in Young Adults 
Kwame 0. Akosah, Sharon I. Barnhart. Troy Haider, Pat Perlock, Jo Bistodeau. Ana M. 
Schaper, Gundersen Lutheran Medical Center, La Crosse, WI 
Background: Preventing premature coronary artery disease (CAD) has been difficult. 
We have previously reported that many young adults suffering myocardial infarctions do 
not have high cholesterol and that the National Cholesterol Education Program guide- 
lines (NCEP Ill) fail to appreciate disease risk. Our objective was to evaluate high sensi- 
tivity C-reactive protein (Hs-CRP), low dense lipoprotein (LDL) particle size, and carotid 
ultrasound (CU) for the ability to predict angiographic CAD in a group of young adults 
scheduled for coronary angiography. 
Method Subjects scheduled for elective cardiac catheterization were recruited. Subjects 
underwent CU and had blood drawn for Hs-CRP, LDL particle size, and lipoprotein anal- 
ysis (LPA). Subjects were excluded for age (women >65 and men >55 years), Statin ther- 
apy, or known CAD or equivalent. Any coronary stenosis was considered evtdence of 
angiographic disease and aO% stenosis was considered severe disease. Criteria for 
abnormal CU included intima media thickness >l.O cm, focal plaque or calcium deposits. 
Risk score for a tan-year probability of cardiac event was calculated for each patient as 
per the NCEP Ill guidelines. 
Results 147 subjects (73 women, mean age 54 and 74 men, mean age 47) completed 
all tests. LPA was as follows: total 209 +/- 46 mg/dL, LDL 131 +/- 38 mg/dL, HDL 48 +/- 
15 m@dL, and triglyceride 159 +/- 87 m@dL. 20% of subjects had LDL cholesterol < 100 
mgldL and only 17% had >t 60 m@dL. 58 subjects had normal CU and 87 were abnor- 
mal. 75 subjects had normal angiograms and 70 had disease. The sensitivity for CU 
compared to angiogram was 70%. with a negative predictive value of 70% (p = 0.013). 
The odds ratio (OR) for abnormal CU in predicting angiographic disease was 2.3 (Cl: 1.5 
- 4.5). The sensitivity for small dense LDL was 44% specificity 56% (OR: 1.5; Cl: 0.76 
2.9, p = ns). The OR for CRP was 1.3 (p = 0.5, Cl: 0.65 - 2.5). Multiple regression 
revealed that only CU abnormalities independently predicted coronary angiographic dis- 
ease. LDL particle size and Hs-CRP had no additional benefit. 
Conclusion: In the evaluation of premature CAD in young adults with low cholesterol, 
CU predicts angiographic disease and is superior to LDL particle size and Hs-CRP. 
1107-143 Which Lipid/Lipoprotein Ratio Best Predicts 
Angiographic Coronary Artery Disease? 
Tami L. Bair, Joseph B. Muhlestein. John F. Carlquist. Chloe A. Allen Maycock. Robert 
R. Pearson, Sandra P. Reyna. Benjamm D. Home, Jeffrey L. Anderson, LDS Hospital, 
Salt Lake City, UT, University of Utah, Salt Lake City, UT 
Backgrounct Various lipid or lipoprotein (LP) ratios have been proposed as a single, 
composite lipid-related risk factor (i.e., total cholesterol [TC]/high density lipoprotein cho- 
lesterol [HDLJ, low density lipoprotein-C [LDL]/HDL, non-HDUHDL, and triglycerides 
[TG]/HDL). These derived measures have not, however, been assessed and compared 
as predictors of angiographic coronary artery disease (CAD). 
Methods We evaluated the predictive value for angiographic CAD of TC/HDL, LDU 
HDL, non-HDUHDL, and TG/HDL ratios, and individual LP fractions in a consecutive 
serves of consenting, prospectively assessed patients. Acute Ml at presentation was 
excluded. Fasting LPs were measured at the time of angiography after an overnight fast 
and assayed by colorimety (Vitros 950). Anglography was performed prior to LP and LP 
ratio determinations. Analysis used logistic regression. 
Results Patients (N=4,724) averaged 63113 years of age; 66% were male. Significant 
CAD @70% stenosl?.) was found in 54%, mild/moderate CAD I” ll%, and no CAD 
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(<IO% stenosis) in 35%. All 4 LP ratios univariately predicted significant (compared to 
no) CAD, in the order of: LDUHDL (Wald chi-square 108, odds ratio [OR]=l.30, 95% Cl 
1.24-l .36), TC/HDL (chi-square 105, OR=1 21, Cl 1.17-I .26), NonHDUHDL @hi-square 
105, O&1.21, Cl 1.17-1.26), TG/HDL (chi-square 33, ORzl.06, Cl 1.04-1.08) (each 
p<O.OOl). Individually, HDL, LDL, nonHDL-C, and TC (trend), but not TG, predicted CAD. 
In multivariable (MV), stepwise modeling considering the 4 LP ratios and 4 LP fractions, 
HDL and LDL were selected as LP-related CAD predictors. In further MV modeling con- 
sidering 6 traditional risk factors, with analysis restricted to younger patlents (men ~55 
years, women ~65 years), age, HDL, LDL, hypertension, smoking, and diabetes were 
selected as independent predictors of CAD. 
Conclusions: Of 4 advocated risk-associated LP ratios, we found 3 to be roughly equiv- 
alent (LDUHDL, nonHDUHDL, and TC/HDL) for predicting angiographic CAD and TG/ 
HDL to be less predictive. However, both in models including lipid measures only and in 
those also including traditional risk factors, none of the ratios was superior to HDL and 
LDL (considered separately). 
1107-144 Preventing Coronary Events by Control of Lipids and 
Blood Pressure in Persons With the Metabolic 
Syndrome 
Nathan D. Wonq, Jose R. Pio. Stanley S. Franklin, Gilbert J. L’ltalien. Tripthi V. Kamath, 
G. Rhys Williams, University of California Irvine. Irvine. CA, Bristol Meyers-Squibb, 
Princeton, NJ 
Background The metabolic syndrome (Mets) is associated with significant risk for coro- 
nary heart disease (CHD). We estimated CHD events preventable by treatment of lipids 
and blood pressure in persons with Mets. 
Methods Among persons aged 30-74 years (without diabetes or CHD) in the United 
States, Mets was defined by the National Cholesterol Education Program criteria. 
Expected CHD events over IO years were estimated by Framingham algorithms. Incre- 
mental benefit was estimated in terms of CHD events that could be potentially prevented 
by StatistIcally “controlling’ blood pressure, LDL-C, and HDL-C to either “normal’ (120. 
129 mmHg systolic (SBP) / 80-84 mmHg diastolic blood pressure (DBP), HDL-C 45-49 
mg/dl in males and 50-59 mg/dl in females, and LDL-C to loo-129 mg/dl) or “optimal 
(~120 mmHg SBP I<80 mmHg DBP, HDL-C to ) 60 mg/dl, and CDL-C to cl00 mgidl) 
levels. Population attributable risks (PARS) for the proportion of CHD events that could 
be prevented were calculated. 
Results Of an estimated 7.5 million men and 8.9 million women with Mets, approxi- 
mately 1.5 million men and 0.45 million women, if risk factors were left uncontrolled, 
would suffer CHD events in 10 years. In men and women, BP control to normal levels 
“prevented’ 28.1% and 12.5% of CHD events (p<O.Ol), respectively, while optimal BP 
control resulted in PARS of 28.2% and 45.2%, respectively (p.zO.01). Control of HDL-C to 
normal levels resulted in PARS of 25.3% in men and 27.3% in women. while control to 
optimal levels gave PARS of 51.2% and 50.6%, respectively. Control of LDL-C to normal 
levels prevented only 9.3% of events in men and 9.8% of events in women, but optimal 
control prevented 46.2% and 38.1% of events (pcO.O5), respectively. Control of all three 
risk factors to normal levels resulted in PARS of 51.3% for men and 42.6% for women. 
whereas control to optimal levels resulted in PARS of 80.5% and 82.1%, respectively. 
Conclusion Up to half of CHD events in persons with Mets may be preventable with con- 
trol of lipids and blood pressure to normal levels, and four-fifths of events may be pre- 
ventable with optimal control. Whether hypothetical control of risk factors as projected is 
similar to actual risk reduction requires further investigation. 
1107-145 Using Carotid Atherosclerosis as a Replacement for 
Age: Effect on National Cholesterol Education Program 
Risk Classification 
Michael C. Fraizer, Pamela S. Douglas, Susan E. Aeschlimann, Jane Nelson-Worel, 
Patrick E. McBride, James H. Stein, University of Wisconsin Medical School, Madison, 
WI 
Introduction: The National Cholesterol Education Program Adult Treatment Panel 
(NCEP ATP Ill) recommends Framingham global risk assessment to classify risk of 
future coronary events. Framingham risk estimates are influenced strongly by chronolog- 
ical age (CA), however atherosclerotic burdens of individuals of the same CA may differ 
substantially. We investigated the impact of carotid intima-media thickness (CIMT) mea- 
surement, an ultrasound measure of current atherosclerotic burden, on Individual risk 
prediction and classification using the NCEP ATP Ill guidelines. 
Methods: CIMT was measured in 82 consecutive subjects who were free of coronary 
heart disease. Far wall thicknesses of three carotid arterial segments were measured on 
each side and averaged to define a composite CIMT. Vascular age (VA) was determined 
by linear regression models of nomograms from the Atherosclerosis Risk in Communities 
Study. VA was substituted for CA In the Framingham risk model for hard coronary 
events, resulting in modified IO-year hard coronary risk estimates. Odds ratios (OR) 
were determined for prediction of re-classification of coronary risk. 
Results: Although the mean CA was 55.8+9.0 years, the mean VA using CIMT values 
was 65.4Al8.9 years (pcO.001). The mean risk estimate for coronary events was 
6.5r4.4%. Substituting VA for CA increased the mean risk estimate to 8.0+6.8% 
(p<O.OOl). Use of modified risk estimates re-classified 12 (15%) subjects into higher risk 
and 3 (3.8%) subjects into lower risk groups. Of 14 subjects initially at intermediate risk, 5 
(35.7%) were re-classified as higher and 2 (14.3%) were re-classified as lower wk. Sig- 
nificant predictors (~~0.05) of re-classification were tobacco use (OR 19.83), high-den- 
sity lipoprotein cholesterol (OR 0.81), systolic blood pressure (OR 1.09), and low-density 
lipoprotein cholesterol (OR 1.02) (chi-square goodness of fit = 36.2, p=O.999). 
Conclusions: Vascular age, determined by CIMT, altered NCEP ATP III risk classifica- 
tion in 50% of intermediate-risk subjects. Assessment of current atherosclerotic burden 
using CIMT may help clinicians tailor primary prevention strategies to an individual 
patient’s risk of a first coronary event. 
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1130MP-163 Effects of Insulin Resistance on Flow: Mediated Dilation 
of Conduit Vessels 
Umberto Campia, Gail Sullivan, Melissa B. Bryant, Michael J. Quon. Julio A. Panza, 
National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 
Background: Insulin resistance is a major link between metabolic risk factors and ath- 
erosclerotic vascular disease. Whether insulin resistance affects conduit vessel endothe- 
lial function is unknown. This investigation aimed to assess the effects of insulin 
resistance on flow-mediated dilation in normotensive. normoglycemic subjects with a 
spectrum of lipid profile. 
Methods: 25 normoglycemic, normotensive subjects participated in the study. Endothe- 
lium-dependent (flow-mediated dilation, FMD) and -independent (nitroglycerin-mediated 
dilation, NMD) responses of the brachial artery were studied by high-resolution ultra- 
sound, and insulin sensitivity (SIClamp) was measured by euglycemlc clamp. To evaluate 
the effects of llpid profile on insulin sensitivity and FMD, participants were divided in 2 
subgroups (normal cholesterol, NC; and high cholesterol, HC) based on their total cho- 
lesterol levels, with a cutoff of 200 mg/dL. 
Results: In the whole group, FMD was directly correlated with SIClamp (r=O.512, P~0.01) 
and inversely correlated with total cholesterol levels (r=-0.57, P=O.O05). No correlation 
was observed between NMD and Slclamp (r=O.ll, P=O.625). S&,,p was significantly 
lower in the HC compared to the NC participants (7*1 vs 12.3+1.7; P=O.O2, respectively). 
FMD was lower in the HC compared to the NC subjects (4.4+0.7% vs &0.7%, respec- 
tively; P=O.O02). In the HC subjects, FMD was significantly correlated with SIclamp 
(w0.715, P=O.O06), but not with total cholesterol levels (r=0.123, P=O.675), whereas no 
significant relationship was noted between FMD and SI Clamp (r-0.219, P=O.57), and 
between FMD and total cholesterol levels (r=-0.227, P=O.50) in the NC subjects. 
Conclusion: In normotensive, normoglycemlc subjects. conduit vessel endothellal func- 
tion directly correlates with insulin sensitivity, suggesting a potential mechanism by which 
insulin resistance might predispose to vascular damage. 
3:12 p.m. 
1130MP-164 Endothelial Function and Inflammatory Process in 
Young Patients With Beta-Thalassemia Major 
Constadina Aaqeli. Christine Chrysohoou, Spyros Lambrou, Alexadra Frogoudaki, 
Charis Antoniadis. Dimitrios Tousoulis. Markisia Karageorga. Dimitrios Ladis, Christos 
Pitsavos, Christodoulos Stefanadis, Pavlos Toutouzas, Hippokration Hospital of Athens, 
Athens, Greece 
Background: Endothelium plays an important role in the modulation of vascular tone 
and structure while its dysfunction may be representative of vascular inflammation. The 
aim of this study was to identify the endothelial function and to determlne the inflamma- 
tory factors in transfusion-dependent patients with beta-thalassemia. 
Methods: Twenty young transfusion-dependent patients (pts) with beta-thalassemia 
(age 27+5 years, 15 male, serum ferritin 2180*1150 ngiml) and 20 matched by sex and 
age controls, without any evidence of cardiac disease or diabetes mellitus were included 
In the study. In all subjects, we evaluated the endothelial function as well as serum 
inflammatory markers level, l-2 days before the scheduled transfusion in the case of pts. 
Endothelium dependent flow mediated vasodilation (FMD) was expressed as the % 
change from baseline to post reactive hyperemia blood flow. Endothelium independent 
flow (NTG%) was expressed as the % change from baseline to post sublingual adminis- 
tration flow. Serum sVCAM-I, slCAM-I, TNF-a, and IL-I beta were measured. 
Results: FMD (%) was significantly lower in pts compared to controls (55.8+4 vs. 
110*16. ~~0.05). NTG% and sICAM-1 (ngiml) were not different between pts and con- 
trols. The levels of sVCAM-1 (ng/ml), TNF-a (pglml). and IL-I beta (pg/ml) I” the serum of 
pts were higher than those of the controls (931.6+180 vs. 295.1*28, 6.65e2.1 vs. 
1.2&0.15, 5.4&l .6 vs. 0.1 l&O 013, ~~0.05, respectively). No correlation was found 
between FMD and serum ferritin levels. All the results were adjusted for the smoking sta- 
tus of the subjects enrolled 
Conclusion: Transfusion-dependent pts with beta-thalassemia are associated with 
endothelial dysfunction. sVCAM-1, TNF-a, and IL-lbeta serum levels are elevated in this 
group of pts. These findings expand our understanding in vascular function and 
increased incidence of cardiovascular events in beta-thalassemia pts possible related to 
a vascular inflammatory process. 
